Stable isotope dilution analysis of N-acetylaspartic acid in urine by liquid chromatography electrospray ionization tandem mass spectrometry

Biomedical Chromatography

Volumn 21, Issue 9, 2007, Pages 898-902

  Al Dirbashi, Osama Y ^a   Rashed, Mohamed S ^a   Al Mokhadab, Manhal A ^a   Al Qahtani, Khalid ^a   Al Sayed, Moeen A A ^a   Kurdi, Wesam ^a  

^a KING FAISAL SPECIALIST HOSPITAL AND RESEARCH CENTER   (Saudi Arabia)

Author keywords

Canavan disease; Electrospray ionization; LC MS MS; Multiple reaction monitoring; N acetylaspartic acid

Indexed keywords

BODY FLUIDS; COLUMN CHROMATOGRAPHY; ISOTOPES; LIQUID CHROMATOGRAPHY; MASS SPECTROMETRY; NEGATIVE IONS; QUALITY CONTROL;

CANAVAN DISEASE; ELECTROSPRAY IONIZATION TANDEM MASS SPECTROMETRY; ISOTOPE DILUTION ANALYSIS; LC-MS-MS; LC.MS/MS; LIQUID CHROMATOGRAPHY ELECTROSPRAY; MULTIPLE REACTION MONITORING; N-ACETYLASPARTIC ACID; STABLE ISOTOPE DILUTION; URINARY MARKERS;

ELECTROSPRAY IONIZATION;

ACETONITRILE; DEUTERIUM; FORMIC ACID; N ACETYLASPARTIC ACID;

AMINO ACID ANALYSIS; AMINO ACID URINE LEVEL; ANALYTIC METHOD; ARTICLE; CALIBRATION; CANAVAN DISEASE; CHILD; CONTROLLED STUDY; DERIVATIZATION; DIAGNOSTIC VALUE; ELECTROSPRAY MASS SPECTROMETRY; FLOW RATE; HUMAN; INFANT; ISOTOPE DILUTION ASSAY; LIQUID CHROMATOGRAPHY; NEGATIVE ION ELECTROSPRAY; NEWBORN; QUALITY CONTROL; RETROSPECTIVE STUDY; SENSITIVITY AND SPECIFICITY; TANDEM MASS SPECTROMETRY; TURNAROUND TIME; URINALYSIS; VALIDATION PROCESS;

EID: 34547975627     PISSN: 02693879     EISSN: 10990801     Source Type: Journal    
DOI: 10.1002/bmc.815     Document Type: Article

References (22)

1. Al Dirbashi OY, Rashed MS, Brink HJ, Jakobs C, Filimban N, Al Ahaidib LY, Jacob M, Al Sayed M, Al Hassnan Z and Faqeih E. Determination of succinylacetone in dried blood spots and liquid urine as a dansylhydrazine by liquid chromatography tandem mass spectrometry. Journal of Chromatography B 2006; 831: 274.
2. Beaudet AL. Aspartoacylase deficiency (Canavan disease). In: The Metabolic and Molecular Basis of Inherited Disease, 7th edn, Scriver CR, Beaudet AL, Sly WS, Valle D (eds). McGraw-Hill: New York, 1995; 4599.
3. Elpeleg ON and Shaag A. The spectrum of mutations of the aspartoacylase gene in Canavan disease in non-jewish patients. Journal of Inherited Metabolic Disease 1999; 22: 531.
4. Engelke UFH, Liebrand-Van Sambeek MLF, De Jong JGN, Leroy JG, Morava E, Smeitink JAM and Wevers RA. N-acetylated metabolites in urine: proton nuclear magnetic resonance spectroscopic study on patients with inborn errors of metabolism. Clinical Chemistry 2004; 50: 58.
5. Gordon N. Canavan disease: a review of recent developments. European Journal of Pediatric Neurology 2000; 5: 65.
6. Hartmann S, Okun JG, Schmidt C, Langhans CD, Garbade SF, Burgard P, Haas D, Sass JO, Nyhan WL and Hoffmann GF. Comprehensive detection of disorders of purine and pyrimidine metabolism by HPLC with electrospray ionization tandem mass spectrometry. Clinical Chemistry 2006; 52: 1127.
7. Howell VM, Proos AL, LaRue D, Jansen CH, Beach F and Burnett L. Carrier screening for Canavan disease in Australia. Journal of Inherited Metabolic Disease 2004; 27: 289.
8. Inoue Y and Kuhara T. Rapid and sensitive screening for and chemical diagnosis of Canavan disease by gas chromatography-mass spectrometry. Journal of Chromatography B 2004; 806: 33.
9. Jakobs C, ten Brink HJ, Langelaar SA, Zee T, Stellaard F, Macek M, Srsnova K, Srsen S and Kleijer WJ. Stable isotope dilution analysis of N-acetylaspartic acid in CSF, blood, urine and amniotic fluid: accurate postnatal diagnosis and the potential for prenatal diagnosis of Canavan disease. Journal of Inherited Metabolic Disease 1991; 14: 653.
10. Janson CG, Assadi M, Francis J, Bilaiuk L, Shera D and Leone P. Lithium citrate for Canavan disease. Pediatric Neurology 2005; 33: 235.
11. Kelly RI and Stamas JN. Quantification of N-acetyl-L-aspartic acid in urine by isotope dilution gas chromatography-mass spectrometry. Journal of Inherited Metabolic Disease 1992; 15: 97.
12. Lacey JM, Minutti CZ, Magera MJ, Tauscher AL, Casetta B, McCann M, Lymp JF, Hahn SH, Rinaldo P and Matern D. Improved specificity of newborn screening for congenital adrenal hyperplasia by second-tier profiling using tandem mass spectrometry. Clinical Chemistry 2004; 50: 621.
13. Leis HJ, Ozand PT, Al Odaib A and Gleishpach H. Quantitative measurment of N-acetyl-L-aspartic acid in urine by gas chromatography with negative-ion chemical ionization mass spectrometry. Journal of Chromatography 1992; 578: 116.
14. Liu A, Kushnir MM, Roberts WL and Pasquali M. Solid phase extraction procedure for urinary organic acid analysis by gas chromatography mass spectrometry. Journal of Chromatography and Biomedical Applications 2004; 806: 283.
15. Matalon R, Kaul RK, Casanova J, Michals K, Johnson A, Rapin I, Gashkoff P and Deanching M. Aspartoacylase deficiency: the enzyme defect in Canavan disease. Journal of Inherited Metabolic Disease 1989; 12: 329.
16. Matalon R, Kaul R and Michals K. Canavan disease: Biochemical and molecular studies. Journal of Inherited Metabolic Disease 1993; 16: 744.
17. Matalon R and Michals-Matalon K. Molecular basis of Canavan disease. European Journal of Pediatric Neurology 1998; 2: 69.
18. Ozand PT, Feryal RR, Gascon GG, Gleispach H, Al Aqeel A, Cook JD, Nester MJ, Al Odaib A and Leis HJ. Prenatal detection of Canavan disease. The Lancet 1991; 337: 735.
19. Rady PL, Penzien JM, Vargas T, Tyring SK and Matalon R. Novel splice site mutation of aspartoacylase gene in a Turkish patient with Canavan disease. European Journal of Pediatric Neurology 2000; 4: 27.
20. Rashed MS, Jacob M, Al Amoudi M, Rahbeeni Z, Al Sayed MA, Al Ahaidib L, Saadallah AA and Legaspi S. Rapid determination of orotic acid in urine by liquid chromatography-electrospray tandem mass spectrometry. Clinical Chemistry 2003; 49: 499.
21. Traeger EC and Rapin I. The clinical course of Canavan disease. Pediatric Neurology 1998; 18: 207.
22. Zafeiriou DI, Kleijer WJ, Marpoulos G, Anastasiou AL, Augoustidou-Savvopoulou P, Papadopoulou F, Kontopoulos EE, Fagan E and Payne S. Protracted course of N-acetylaspartic aciduria in two non-Jewish siblings: identical clinical and magnetic resonance imaging findings. Brain Development 1999; 21: 205.